We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sudden Cardiac Death Risk for Patients on Dialysis

By HospiMedica International staff writers
Posted on 05 Nov 2008
Sudden cardiac death (due to systemic inflammatory response and malnutrition) is emerging as the number one cause of death for patients on dialysis, according to a new study.

Researchers at Johns Hopkins University (JHU, Baltimore, MD, USA) conducted a 10-year study of a cohort of 1,041 end-stage renal disease (ESRD) patients on dialysis. More...
During this period, 658 of this group died; the largest number of deaths, involving 146 patients, was the result of sudden cardiac death (SCD), in this study representing unexpected deaths that occurred outside of the hospital setting. The researchers then looked at previously recorded blood test results of 122 of these 146 SCD patients to search for a possible relationship between the deaths and levels of high-sensitivity C-reactive (hsCRP), interlukin-6 (IL-6)--which are markers for widespread blood vessel and organ inflammation--and albumin, low levels of which are associated with malnutrition.

The study results showed that patients with high levels of either hsCRP or IL-6 were twice as likely to die from SCD as those with low levels of these proteins were. Low albumin levels were associated with a 1.35 times increase in the risk of dying of SCD when compared with high levels. In addition, those with low levels of albumin and high levels of hsCRP were four times more likely to die of SCD than those with high levels and albumin and low levels of hsCRP were. The study was published in the November 2, 2008, issue of Kidney International.

"This is believed to be the first time anyone has taken a rigorous prospective look at why so many patients on dialysis die from sudden cardiac death, and the results could help doctors identify those at highest risk and potentially save lives,” said lead author Rulan Parekh, M.D., an associate professor in the department of nephrology at JHU. "When people think of heart attacks, they think of cholesterol and obesity; but these are risk factors for hardening of the arteries and are not directly linked to sudden heart death among patients on dialysis.”

ESRD, also known as chronic kidney failure (CKF) or chronic renal failure (CRF) is determined as stage 5 of chronic kidney disease (CKD), as measured by a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 m², or by the need for permanent renal replacement therapy (RRT).

Related LInks:
Johns Hopkins University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.